Danny Tam

1.8k total citations
25 papers, 870 citations indexed

About

Danny Tam is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Danny Tam has authored 25 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Danny Tam's work include Liver Disease Diagnosis and Treatment (4 papers), Neural dynamics and brain function (3 papers) and Computational Drug Discovery Methods (3 papers). Danny Tam is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Neural dynamics and brain function (3 papers) and Computational Drug Discovery Methods (3 papers). Danny Tam collaborates with scholars based in United States, Australia and Türkiye. Danny Tam's co-authors include Gerald McMahon, Michael P. Bova, Joshua C. Brumberg, Julie C. Lougheed, Jens Oliver Funk, Tal Zaks, Joel Greshock, Jenny Tan, Tracy Lou and Kwang‐Ai Won and has published in prestigious journals such as PLoS ONE, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Danny Tam

25 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danny Tam United States 14 449 144 142 135 119 25 870
Christophe Frémin France 15 650 1.4× 201 1.4× 165 1.2× 112 0.8× 33 0.3× 17 1.0k
Gengjie Yang United States 13 291 0.6× 289 2.0× 100 0.7× 50 0.4× 87 0.7× 21 814
Melanie Wong United States 17 418 0.9× 156 1.1× 26 0.2× 35 0.3× 160 1.3× 23 830
Peter K. Harris United States 14 620 1.4× 267 1.9× 38 0.3× 78 0.6× 50 0.4× 33 1.3k
William R. Schelman United States 19 622 1.4× 588 4.1× 280 2.0× 84 0.6× 46 0.4× 81 1.5k
Christopher J. Strock United States 15 413 0.9× 336 2.3× 18 0.1× 73 0.5× 64 0.5× 24 848
Lee Fy Taiwan 10 428 1.0× 63 0.4× 74 0.5× 21 0.2× 34 0.3× 29 844
Fumihito Hosoi Japan 15 933 2.1× 418 2.9× 27 0.2× 145 1.1× 59 0.5× 22 1.3k
T Sethi United Kingdom 17 542 1.2× 422 2.9× 75 0.5× 42 0.3× 21 0.2× 37 1.1k
Mahmut Yilmaz Switzerland 7 681 1.5× 435 3.0× 116 0.8× 78 0.6× 22 0.2× 7 1.3k

Countries citing papers authored by Danny Tam

Since Specialization
Citations

This map shows the geographic impact of Danny Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Tam more than expected).

Fields of papers citing papers by Danny Tam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Tam. The network helps show where Danny Tam may publish in the future.

Co-authorship network of co-authors of Danny Tam

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Tam. A scholar is included among the top collaborators of Danny Tam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Tam. Danny Tam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doğan, İsmail, et al.. (2025). Urinary total superoxide dismutase activity is low in rheumatoid patients, and its low levels are associated with higher DAS28 scores. Free Radical Biology and Medicine. 233. 77–85. 1 indexed citations
2.
Venetsanakos, Eleni, Ken A. Brameld, Vernon T. Phan, et al.. (2017). The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance. Molecular Cancer Therapeutics. 16(12). 2668–2676. 22 indexed citations
3.
Tam, Danny, Ryan A. Dick, T.C. Appleby, et al.. (2017). Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model. Journal of Hepatology. 66(1). S690–S691. 31 indexed citations
4.
5.
Dick, Ryan A., Mike Matles, Danny Tam, et al.. (2017). In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus. Journal of Hepatology. 66(1). S263–S263. 5 indexed citations
6.
Hill, Ronald J., J. Michael Bradshaw, Angelina Bisconte, et al.. (2015). THU0068 Preclinical Characterization of PRN1008, a Novel Reversible Covalent Inhibitor of BTK that Shows Efficacy in a RAT Model of Collagen-Induced Arthritis. Annals of the Rheumatic Diseases. 74. 216–217. 9 indexed citations
7.
Xu, Ying‐zi, Shendong Yuan, Simeon Bowers, et al.. (2013). Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3075–3080. 21 indexed citations
8.
Garofalo, Albert W., Marc Adler, Danielle L. Aubele, et al.. (2013). Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1974–1977. 23 indexed citations
9.
Ren, Zhao, Danny Tam, Ying‐zi Xu, et al.. (2013). Development of a Novel β-Secretase Binding Assay Using the AlphaScreen Platform. SLAS DISCOVERY. 18(6). 695–704. 6 indexed citations
10.
Tam, Danny, et al.. (2013). Dominance of Orientation over Frequency in the Perception of 3-D Slant and Shape. PLoS ONE. 8(5). e64958–e64958. 2 indexed citations
11.
Franzini, Maurizio, Marc Adler, Danielle L. Aubele, et al.. (2013). Triazolopyridazine LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1967–1973. 24 indexed citations
12.
Bowers, Simeon, Ying‐zi Xu, Shendong Yuan, et al.. (2013). Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates. Bioorganic & Medicinal Chemistry Letters. 23(7). 2181–2186. 10 indexed citations
13.
Garofalo, Albert W., Marc Adler, Danielle L. Aubele, et al.. (2012). Novel cinnoline-based inhibitors of LRRK2 kinase activity. Bioorganic & Medicinal Chemistry Letters. 23(1). 71–74. 30 indexed citations
14.
Chen, Chia‐Chien, Danny Tam, & Joshua C. Brumberg. (2011). Sensory deprivation differentially impacts the dendritic development of pyramidal versus non-pyramidal neurons in layer 6 of mouse barrel cortex. Brain Structure and Function. 217(2). 435–446. 13 indexed citations
15.
Qian, Fawn, Stefan Engst, Toshihiro Yamaguchi, et al.. (2009). Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases. Cancer Research. 69(20). 8009–8016. 282 indexed citations
16.
Ramos, Raddy L., et al.. (2008). Cytoarchitecture and Transcriptional Profiles of Neocortical Malformations in Inbred Mice. Cerebral Cortex. 18(11). 2614–2628. 28 indexed citations
17.
Ramos, Raddy L., Danny Tam, & Joshua C. Brumberg. (2008). Physiology and morphology of callosal projection neurons in mouse. Neuroscience. 153(3). 654–663. 31 indexed citations
18.
Bova, Michael P., et al.. (2004). Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells. Toxicology Letters. 155(1). 41–50. 68 indexed citations
19.
Bova, Michael P., Stefan Vasile, Danny Tam, et al.. (2004). The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase α is mediated by hydrogen peroxide. Archives of Biochemistry and Biophysics. 429(1). 30–41. 48 indexed citations
20.
Sun, Li, Deborah Moshinsky, Hui Chen, et al.. (2003). A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability. Journal of Pharmacology and Experimental Therapeutics. 306(3). 838–845. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Frémin Breakdown of academic impact, for papers by Gengjie Yang Breakdown of academic impact, for papers by Melanie Wong Breakdown of academic impact, for papers by Peter K. Harris Breakdown of academic impact, for papers by William R. Schelman Breakdown of academic impact, for papers by Christopher J. Strock Breakdown of academic impact, for papers by Lee Fy Breakdown of academic impact, for papers by Fumihito Hosoi Breakdown of academic impact, for papers by T Sethi Breakdown of academic impact, for papers by Mahmut Yilmaz
Rankless by CCL
2026